Effect of perioperative intravenous infusion of lidocaine on the postoperative course and the immune response in patients undergoing surgery for colon cancer - the PILDI study

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521808-22-01

Acronym

ORI2025-16

Enrollment

100

Registered

2025-10-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Brief summary

Total opioid analgesic consumption in both groups during the first 24 hours after the surgical procedure, expressed in mg.

Detailed description

Time to first postoperative bowel movement in patients of both groups (measured in hours from the end of the surgical procedure).

Interventions

DRUGSODIUM CHLORIDE

DRUGLIDOCAINE HYDROCHLORIDE MONOHYDRATE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Total opioid analgesic consumption in both groups during the first 24 hours after the surgical procedure, expressed in mg.	—

Secondary

Measure	Time frame
Time to first postoperative bowel movement in patients of both groups (measured in hours from the end of the surgical procedure).	—

Countries

Slovenia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026